BQ.1.1 subvariant of COVID is more contagious and it explains the current surge in the number of new cases.
COVID-19 Variant BQ.1.1 Subvariant
Brigitte Autran, president of the Committee for Monitoring and Anticipating Health Risks (COVARS), told the news channel BFMTV on Wednesday that the latest COVID-19 resurgence is the “beginning of a wave", even though the increase in the number of cases is "not significant yet", reports Xinhua news agency. “The trend is not good, it is up” because of the subvariant of the virus, she said.
COVID in Children | Guidelines for Management of COVID-19 in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
‘BA.5, the subvariant of the original Omicron subvariant that has been prevalent in France, has already been replaced, swept away by the BQ.1.1 subvariant, which is the baby of BA.5.’
Autran said that the BQ.1.1 subvariant is currently being observed all over the world. “We do not yet know if it is meaner, but it is understood to be more contagious, and therefore it is absolutely necessary to get protected and vaccinated. She called on the eligible population to get booster shots, arguing that vaccines guarantee protection against severe forms of COVID and against death”.
She also reiterated the need to respect barrier measures, including wearing masks, at least on public transport and in crowded spaces.
Omicron Variant of COVID-19
Omicron variant is a mutated strain of coronavirus (SARS-CoV-2) with faster transmissibility and enhanced virulence compared to the original COVID-19 virus.
Omicron variant is a mutated strain of coronavirus (SARS-CoV-2) with faster transmissibility and enhanced virulence compared to the original COVID-19 virus.
Second Bivalent COVID-19 Booster Targeting Omicron Variants Approved
Health Canada approved the bivalent COVID-19 vaccine for use as a booster dose in individuals 18 years of age or older,
Health Canada approved the bivalent COVID-19 vaccine for use as a booster dose in individuals 18 years of age or older,
XBB Variant of Omicron Emerges as Dominant in India
Omicron's XBB variant emerges as dominant in India, and Tamil Nadu tops the number.
Omicron's XBB variant emerges as dominant in India, and Tamil Nadu tops the number.
